BACKGROUND: Dupilumab is an IL-4R
- Mümmler, C.
- Lenoir, A.
- Götschke, J.
- Gerckens, M.
- Kaiser, M.
- Kayser, M.
- Drick, N.
- Suhling, H.
- Biener, L.
- Pizarro, C.
- Skowasch, D.
- Kneidinger, N.
- Behr, J.
- Milger, K.
Keywords
- Severe asthma
- antibody
- dupilumab
- long-term
- real-world
